{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:32:05Z","timestamp":1784662325205,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"DOI":"10.1186\/s40795-024-00989-w","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:35:26Z","timestamp":1736260526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effects of kefir drink on liver aminotransferases and metabolic indicators in patients with nonalcoholic fatty liver disease: a randomized controlled trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Farzaneh","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Razmjooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Mohsenpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Nejati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"989_CR1","doi-asserted-by":"crossref","first-page":"e000315","DOI":"10.1136\/bmjgast-2019-000315","volume":"6","author":"A Duseja","year":"2019","unstructured":"Duseja A, Acharya SK, Mehta M, Chhabra S, Rana S, Das A, Dattagupta S, Dhiman RK, Chawla YK. High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study. BMJ open Gastroenterol. 2019;6:e000315.","journal-title":"BMJ open Gastroenterol"},{"key":"989_CR2","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/nu11112642","volume":"11","author":"M Meroni","year":"2019","unstructured":"Meroni M, Longo M, Dongiovanni P. The role of probiotics in nonalcoholic fatty liver disease: a new insight into therapeutic strategies. Nutrients. 2019;11:2642.","journal-title":"Nutrients"},{"key":"989_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","volume":"38","author":"AR Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease\/non\u2010alcoholic steatohepatitis: what we need in the future. Liver Int. 2018;38:47\u201351.","journal-title":"Liver Int"},{"key":"989_CR4","first-page":"149","volume":"7","author":"I Moghaddasifar","year":"2016","unstructured":"Moghaddasifar I, Lankarani K, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, Gharebagh RA, Malary M. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Transplantation Med. 2016;7:149.","journal-title":"Int J Organ Transplantation Med"},{"key":"989_CR5","doi-asserted-by":"crossref","unstructured":"Amini-Salehi E, Hassanipour S, Joukar F, Daryagasht AA, Khosousi M-J, Aleali MS, Ansar MM, Heidarzad F, Abdzadeh E, Vakilpour A. Risk factors of non-alcoholic fatty liver disease in the Iranian adult population: a systematic review and meta-analysis. Hepat Monthly 2023, 23.","DOI":"10.5812\/hepatmon-131523"},{"key":"989_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13104-024-06923-4","volume":"17","author":"M Sohrabi","year":"2024","unstructured":"Sohrabi M, Amirkalali B, Gholami A, Hajjar M, Sohrabi M, NasiriToosi M, Keyvani H, Zamani F, Doustmohammadian A. The association of food insecurity with non-alcoholic fatty liver disease (NAFLD) in a sample of Iranian adults: a path analysis of a cross-sectional survey. BMC Res Notes. 2024;17:272.","journal-title":"BMC Res Notes"},{"key":"989_CR7","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158:1851\u201364.","journal-title":"Gastroenterology"},{"key":"989_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen F, Zheng R-D, Sun X-Q, Ding W-J, Wang X-Y, Fan J-G. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2017;16:375\u201381.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"989_CR9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1665-2681(19)31246-3","volume":"13","author":"C Buss","year":"2014","unstructured":"Buss C, Valle-Tovo C, Miozzo S, de Mattos AA. Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. Ann Hepatol. 2014;13:482\u20138.","journal-title":"Ann Hepatol"},{"key":"989_CR10","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.3168\/jds.2014-8500","volume":"97","author":"S Nabavi","year":"2014","unstructured":"Nabavi S, Rafraf M, Somi M, Homayouni-Rad A, Asghari-Jafarabadi M. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci. 2014;97:7386\u201393.","journal-title":"J Dairy Sci"},{"key":"989_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","volume":"64","author":"F Famouri","year":"2017","unstructured":"Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R. Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents. J Pediatr Gastroenterol Nutr. 2017;64:413\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"989_CR12","first-page":"1031","volume":"27","author":"L Javadi","year":"2018","unstructured":"Javadi L, Khoshbaten M, Safaiyan A, Ghavami M, Abbasi MM, Gargari BP. Pro-and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. Asia Pac J Clin Nutr. 2018;27:1031\u20139.","journal-title":"Asia Pac J Clin Nutr"},{"key":"989_CR13","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1038\/nutd.2016.49","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen H, Tsai T, Tsai Y, Liao J, Yen C, Chen C. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway. Nutr Diabetes. 2016;6:e237\u2013237.","journal-title":"Nutr Diabetes"},{"key":"989_CR14","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/ijo.2013.236","volume":"38","author":"H Chen","year":"2014","unstructured":"Chen H, Tung Y, Tsai C, Lai C, Lai Z, Tsai H, Lin Y, Wang C-H, Chen C. Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob\/ob knockout mice. Int J Obes. 2014;38:1172\u20139.","journal-title":"Int J Obes"},{"key":"989_CR15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idairyj.2004.07.016","volume":"15","author":"R Witthuhn","year":"2005","unstructured":"Witthuhn R, Schoeman T, Britz T. Characterisation of the microbial population at different stages of kefir production and kefir grain mass cultivation. Int Dairy J. 2005;15:383\u20139.","journal-title":"Int Dairy J"},{"key":"989_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/19476337.2014.981588","volume":"13","author":"S Arslan","year":"2015","unstructured":"Arslan S. A review: chemical, microbiological and nutritional characteristics of kefir. CyTA-Journal Food. 2015;13:340\u20135.","journal-title":"CyTA-Journal Food"},{"key":"989_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40795-023-00732-x","volume":"9","author":"MA Mohsenpour","year":"2023","unstructured":"Mohsenpour MA, Mohammadi F, Razmjooei N, Eftekhari MH, Hejazi N. Milk kefir drink may not reduce depression in patients with non-alcoholic fatty liver disease: secondary outcome analysis of a randomized, single-blinded, controlled clinical trial. BMC Nutr. 2023;9:1\u20139.","journal-title":"BMC Nutr"},{"key":"989_CR18","doi-asserted-by":"crossref","first-page":"1700252","DOI":"10.1002\/mnfr.201700252","volume":"61","author":"DH Kim","year":"2017","unstructured":"Kim DH, Jeong D, Kang IB, Kim H, Song KY, Seo KH. Dual function of Lactobacillus kefiri DH5 in preventing high-fat\u2010diet\u2010induced obesity: direct reduction of cholesterol and upregulation of PPAR\u2010\u03b1 in adipose tissue. Mol Nutr Food Res. 2017;61:1700252.","journal-title":"Mol Nutr Food Res"},{"key":"989_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/HNP.0000000000000310","volume":"33","author":"H \u00d6zcan","year":"2019","unstructured":"\u00d6zcan H, Oskay \u00dc, Bodur AF. Effects of kefir on quality of life and sleep disturbances in postmenopausal women. Holist Nurs Pract. 2019;33:207\u201313.","journal-title":"Holist Nurs Pract"},{"key":"989_CR20","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1017\/S0007114509993801","volume":"103","author":"H Sadrzadeh-Yeganeh","year":"2010","unstructured":"Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr. 2010;103:1778\u201383.","journal-title":"Br J Nutr"},{"key":"989_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"989_CR22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1440-1681.2007.04623.x","volume":"34","author":"F Zal","year":"2007","unstructured":"Zal F, Mostafavi-Pour Z, Vessal M. Comparison of the effects of vitamin e and\/or quercetin in attenuating chronic cyclosporine a\u2010induced nephrotoxicity in male rats. Clin Exp Pharmacol Physiol. 2007;34:720\u20134.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"989_CR23","doi-asserted-by":"crossref","unstructured":"Reaven G. What do we learn from measurements of HOMA-IR? Diabetologia. 2013;56:1867\u20138.","DOI":"10.1007\/s00125-013-2948-3"},{"key":"989_CR24","first-page":"83","volume":"2","author":"IGM AL-Shemmari","year":"2018","unstructured":"AL-Shemmari IGM, Hassan AH. Evaluation of antidiabetic and antihyperlipidimic activity of Kefir in alloxan induced diabetes mellitus rat. Sci J Med Res. 2018;2:83\u20136.","journal-title":"Sci J Med Res"},{"key":"989_CR25","first-page":"411","volume":"18","author":"WI Abd-Alwahab","year":"2018","unstructured":"Abd-Alwahab WI, Al-Dulaimi FK. Effects of kefir as a probiotic on total lipid profile and activity of aspartate amino transferase and alanine amino transferase in serum of human. Biochem Cell Arch. 2018;18:411\u20134.","journal-title":"Biochem Cell Arch"},{"key":"989_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jnutbio.2017.02.014","volume":"44","author":"D-H Kim","year":"2017","unstructured":"Kim D-H, Kim H, Jeong D, Kang I-B, Chon J-W, Kim H-S, Song K-Y, Seo K-H. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. J Nutr Biochem. 2017;44:35\u201343.","journal-title":"J Nutr Biochem"},{"key":"989_CR27","doi-asserted-by":"crossref","first-page":"100266","DOI":"10.1016\/j.phanu.2021.100266","volume":"16","author":"AC da Silva Ghizi","year":"2021","unstructured":"da Silva Ghizi AC, de Almeida Silva M, de Andrade Moraes FS, da Silva CL, Endringer DC, Scherer R, Lenz D, de Lima EM, Brasil GA, Maia JF. Kefir improves blood parameters and reduces cardiovascular risks in patients with metabolic syndrome. PharmaNutrition. 2021;16:100266.","journal-title":"PharmaNutrition"},{"key":"989_CR28","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3390\/nu11092089","volume":"11","author":"E Bellikci-Koyu","year":"2019","unstructured":"Bellikci-Koyu E, Sarer-Yurekli BP, Akyon Y, Aydin-Kose F, Karagozlu C, Ozgen AG, Brinkmann A, Nitsche A, Ergunay K, Yilmaz E. Effects of regular kefir consumption on gut microbiota in patients with metabolic syndrome: a parallel-group, randomized, controlled study. Nutrients. 2019;11:2089.","journal-title":"Nutrients"},{"key":"989_CR29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","volume":"3","author":"S Kersten","year":"2014","unstructured":"Kersten S. Integrated physiology and systems biology of PPAR\u03b1. Mol Metabolism. 2014;3:354\u201371.","journal-title":"Mol Metabolism"},{"key":"989_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-\u03b1 and IL-6. Diabetes Res Clin Pract. 2005;69:29\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"989_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000339066","volume":"30","author":"C Younce","year":"2012","unstructured":"Younce C, Kolattukudy P. MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy. Cell Physiol Biochem. 2012;30:307\u201320.","journal-title":"Cell Physiol Biochem"},{"key":"989_CR32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.ejcn.1601399","volume":"56","author":"G Kiessling","year":"2002","unstructured":"Kiessling G, Schneider J, Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr. 2002;56:843\u20139.","journal-title":"Eur J Clin Nutr"},{"key":"989_CR33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/jn\/129.7.1239","volume":"129","author":"H Vesper","year":"1999","unstructured":"Vesper H, Schmelz E-M, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr. 1999;129:1239\u201350.","journal-title":"J Nutr"},{"key":"989_CR34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","volume":"77","author":"RP Mensink","year":"2003","unstructured":"Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146\u201355.","journal-title":"Am J Clin Nutr"},{"key":"989_CR35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ajcn\/63.6.897","volume":"63","author":"E Temme","year":"1996","unstructured":"Temme E, Mensink RP, Hornstra G. Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr. 1996;63:897\u2013903.","journal-title":"Am J Clin Nutr"},{"key":"989_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-2-1","volume":"2","author":"M-P St-Onge","year":"2002","unstructured":"St-Onge M-P, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJ. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810]. BMC Complement Altern Med. 2002;2:1\u20137.","journal-title":"BMC Complement Altern Med"},{"key":"989_CR37","first-page":"228","volume":"44","author":"A Ostadrahimi","year":"2015","unstructured":"Ostadrahimi A, Taghizadeh A, Mobasseri M, Farrin N, Payahoo L, Gheshlaghi ZB, Vahedjabbari M. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Iran J Public Health. 2015;44:228.","journal-title":"Iran J Public Health"},{"key":"989_CR38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacl.2016.10.016","volume":"11","author":"Y Fathi","year":"2017","unstructured":"Fathi Y, Ghodrati N, Zibaeenezhad M-J, Faghih S. Kefir drink causes a significant yet similar improvement in serum lipid profile, compared with low-fat milk, in a dairy-rich diet in overweight or obese premenopausal women: a randomized controlled trial. J Clin Lipidol. 2017;11:136\u201346.","journal-title":"J Clin Lipidol"},{"key":"989_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/07315724.1999.10718826","volume":"18","author":"JW Anderson","year":"1999","unstructured":"Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr. 1999;18:43\u201350.","journal-title":"J Am Coll Nutr"},{"key":"989_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2621.1996.16-316.x","volume":"31","author":"ME Pintado","year":"1996","unstructured":"Pintado ME, Da Silva JL, Fernandes PB, Malcata FX, Hogg TA. Microbiological and rheological studies on Portuguese kefir grains. Int J Food Sci Technol. 1996;31:15\u201326.","journal-title":"Int J Food Sci Technol"},{"key":"989_CR41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.31989\/ffhd.v4i8.145","volume":"4","author":"J Judiono","year":"2014","unstructured":"Judiono J, Hadisaputro S, Indranila K, Cahyono B, Suzery M, Widiastuti Y, Purnawan AI. Effects of clear kefir on biomolecular aspects of glycemic status of type 2 diabetes mellitus (T2DM) patients in Bandung, West Java [study on human blood glucose, c peptide and insulin]. Funct Foods Health Disease. 2014;4:340\u20138.","journal-title":"Funct Foods Health Disease"},{"key":"989_CR42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/biof.5520220141","volume":"22","author":"H Maeda","year":"2004","unstructured":"Maeda H, Zhu X, Omura K, Suzuki S, Kitamura S. Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation. BioFactors. 2004;22:197\u2013200.","journal-title":"BioFactors"},{"key":"989_CR43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4183\/aeb.2017.431","volume":"13","author":"N Alihosseini","year":"2017","unstructured":"Alihosseini N, Moahboob S, Farrin N, Mobasseri M, Taghizadeh A, Ostadrahimi A. Effect of probiotic fermented milk (kefir) on serum level of insulin and homocysteine in type 2 diabetes patients. Acta Endocrinol (Bucharest). 2017;13:431.","journal-title":"Acta Endocrinol (Bucharest)"},{"key":"989_CR44","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.12659\/MSM.902600","volume":"23","author":"K Yao","year":"2017","unstructured":"Yao K, Zeng L, He Q, Wang W, Lei J, Zou X. Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med Sci Monitor: Int Med J Experimental Clin Res. 2017;23:3044.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"989_CR45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.numecd.2014.07.012","volume":"25","author":"KL Ivey","year":"2015","unstructured":"Ivey KL, Hodgson JM, Kerr DA, Thompson PL, Stojceski B, Prince RL. The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial. Nutr Metabolism Cardiovasc Dis. 2015;25:46\u201351.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"989_CR46","first-page":"0","volume":"6","author":"H Ejtahed","year":"2012","unstructured":"Ejtahed H, Mohtadi Nia J, Homayouni Rad A, Niafar M, Asghari Jafarabadi M, Mofid V. The effects of probiotic yoghurt consumption on blood pressure and serum lipids in type 2 diabetic patients: randomized clinical trial. Iran J Nutr Sci Food Technol. 2012;6:0\u20130.","journal-title":"Iran J Nutr Sci Food Technol"},{"key":"989_CR47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nut.2017.12.007","volume":"51","author":"GA Brasil","year":"2018","unstructured":"Brasil GA, de Almeida Silva-Cutini M, Moraes FSA, Pereira TMC, Vasquez EC, Lenz D, Bissoli NS, Endringer DC, de Lima EM, Biancardi VC. The benefits of soluble non-bacterial fraction of kefir on blood pressure and cardiac hypertrophy in hypertensive rats are mediated by an increase in baroreflex sensitivity and decrease in angiotensin-converting enzyme activity. Nutrition. 2018;51:66\u201372.","journal-title":"Nutrition"},{"key":"989_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jnutbio.2019.01.006","volume":"66","author":"MA Silva-Cutini","year":"2019","unstructured":"Silva-Cutini MA, Almeida SA, Nascimento AM, Abreu GR, Bissoli NS, Lenz D, Endringer DC, Brasil GA, Lima EM, Biancardi VC. Long-term treatment with kefir probiotics ameliorates cardiac function in spontaneously hypertensive rats. J Nutr Biochem. 2019;66:79\u201385.","journal-title":"J Nutr Biochem"},{"key":"989_CR49","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3168\/jds.S0022-0302(05)73032-0","volume":"88","author":"A Quir\u00f3s","year":"2005","unstructured":"Quir\u00f3s A, Hern\u00e1ndez-Ledesma B, Ramos M, Amigo L, Recio I. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. J Dairy Sci. 2005;88:3480\u20137.","journal-title":"J Dairy Sci"},{"key":"989_CR50","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.idairyj.2007.02.009","volume":"17","author":"O Donkor","year":"2007","unstructured":"Donkor O, Henriksson A, Singh T, Vasiljevic T, Shah NP. ACE-inhibitory activity of probiotic yoghurt. Int Dairy J. 2007;17:1321\u201331.","journal-title":"Int Dairy J"},{"key":"989_CR51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/ars.2016.6776","volume":"26","author":"S Spahis","year":"2017","unstructured":"Spahis S, Delvin E, Borys J-M, Levy E. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid Redox Signal. 2017;26:519\u201341.","journal-title":"Antioxid Redox Signal"},{"key":"989_CR52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09712119.2009.9706992","volume":"35","author":"A Ozcan","year":"2009","unstructured":"Ozcan A, Kaya N, Atakisi O, Karapehlivan M, Atakisi E, Cenesiz S. Effect of kefir on the oxidative stress due to lead in rats. J Appl Anim Res. 2009;35:91\u20133.","journal-title":"J Appl Anim Res"},{"key":"989_CR53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10787-017-0436-y","volume":"26","author":"SMA Rudbane","year":"2018","unstructured":"Rudbane SMA, Rahmdel S, Abdollahzadeh SM, Zare M, Bazrafshan A, Mazloomi SM. The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials. Inflammopharmacology. 2018;26:67\u201376.","journal-title":"Inflammopharmacology"},{"key":"989_CR54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12602-018-9500-1","volume":"12","author":"B Zamani","year":"2020","unstructured":"Zamani B, Sheikhi A, Namazi N, Larijani B, Azadbakht L. The effects of supplementation with probiotic on biomarkers of oxidative stress in adult subjects: a systematic review and meta-analysis of randomized trials. Probiotics Antimicrob Proteins. 2020;12:102\u201311.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"989_CR55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nut.2011.08.013","volume":"28","author":"HS Ejtahed","year":"2012","unstructured":"Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28:539\u201343.","journal-title":"Nutrition"},{"key":"989_CR56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1439-0450.2003.00693.x","volume":"50","author":"A G\u00fcven","year":"2003","unstructured":"G\u00fcven A, G\u00fcven A, G\u00fclmez M. The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetrachloride\u2010induced mice tissues. J Veterinary Med Ser B. 2003;50:412\u20136.","journal-title":"J Veterinary Med Ser B"},{"key":"989_CR57","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u201346.","journal-title":"Hepatology"},{"key":"989_CR58","first-page":"0","volume":"19","author":"M Jamilian","year":"2016","unstructured":"Jamilian M, Bahmani F, Vahedpoor Z, Salmani A, Tajabadi-Ebrahimi M, Jafari P, Dizaji SH, Asemi Z. Effects of probiotic supplementation on metabolic status in pregnant women: a randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2016;19:0\u20130.","journal-title":"Arch Iran Med"},{"key":"989_CR59","first-page":"1","volume":"21","author":"M Karamali","year":"2018","unstructured":"Karamali M, Eghbalpour S, Rajabi S, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M, Keneshlou F, Mirhashemi SM, Chamani M, Gelougerdi SH. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2018;21:1\u20137.","journal-title":"Arch Iran Med"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-024-00989-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-024-00989-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-024-00989-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:58:09Z","timestamp":1736330289000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnutr.biomedcentral.com\/articles\/10.1186\/s40795-024-00989-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1186\/s40795-024-00989-w","relation":{},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"28 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (IR.SUMS.REC.1397.107). The study was also conducted following the Helsinki Declarations of Ethics. The informed consent form was completed for all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}